SS-Chr XBN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
11 |
|
0.59 |
IU/g |
0.08 |
0.27 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47507 |
461 |
SS-Chr XBN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
10 |
|
21.82 |
IU/g |
2.57 |
8.12 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
48909 |
461 |
SS-Chr XBN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
11 |
|
11.57 |
ml/min/g |
0.52 |
1.74 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46732 |
461 |
SS-Chr XBN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
69.38 |
% |
6.02 |
19.02 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46145 |
461 |
SS-Chr XBN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
|
8.82 |
ml/min/g |
0.41 |
1.31 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46949 |
461 |
SS-Chr XBN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
61.26 |
% |
6.5 |
19.5 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47145 |
461 |
SS-Chr XBN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
10 |
|
0.25 |
IU/g |
0.04 |
0.14 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47369 |
461 |
SS-Chr XBN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
|
9.86 |
ml/min/g |
0.46 |
1.46 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46721 |
461 |
SS-Chr XBN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
9 |
|
20.17 |
IU/g |
2.03 |
6.09 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
45996 |
461 |
SS-Chr XBN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
80.44 |
% |
10.93 |
34.56 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46134 |
461 |
SS-Chr XBN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
10 |
|
5.97 |
ml/min/g |
0.37 |
1.18 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46281 |
461 |
SS-Chr XBN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
10 |
|
0.34 |
IU/g |
0.04 |
0.13 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47349 |
461 |
SS-Chr XBN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
11 |
|
28.39 |
IU/g |
2.19 |
7.26 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46013 |
461 |
SS-Chr XBN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
|
5.87 |
ml/min/g |
0.59 |
1.78 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
44786 |
461 |
SS-Chr XBN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
10 |
|
0.42 |
IU/g |
0.05 |
0.17 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47485 |
461 |
SS-Chr XBN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
|
9.57 |
ml/min/g |
0.47 |
1.5 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46938 |
461 |
SS-Chr XBN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
11 |
|
7.34 |
ml/min/g |
0.81 |
2.67 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
44797 |
461 |
SS-Chr XBN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
11 |
post-ischemic value/pre-ischemic value x 100% |
62.89 |
% |
5.57 |
18.47 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47156 |
461 |
SS-Chr XBN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
|
7.54 |
ml/min/g |
0.98 |
3.09 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46270 |
461 |
SS-Chr XBN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
10 |
|
18.94 |
IU/g |
2.46 |
7.78 |
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
48895 |
461 |